Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

ScreenIn3D

ScreenIn3D develops a unique microfluidic screening platform for precision medicine.
2018
2-10
Glasgow, Glasgow City, United Kingdom
Precision Medicine

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

1.02M

Last Funding Amount

1.02M

Last Funding Date

12-06-2025

Startup Stage

Seed

Lead Investors

University of Strathclyde, Scottish Enterprise, Nidobirds Ventures, Gabriel Investments, TRICAPITAL

Revenue

Less than $1M